|
|
synaptic transmission
|
GO:0007268 |
329 |
0.676
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.552
|
Mouse |
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.372
|
Mouse |
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.356
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.350
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.305
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.276
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.270
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.242
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.226
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.220
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.217
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.206
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.204
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.197
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.191
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.190
|
Mouse |
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.189
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.183
|
Mouse |
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.181
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.171
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.170
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.166
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.161
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.153
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.151
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.142
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.140
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.137
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.136
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.135
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.134
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.133
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.133
|
Mouse |
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.132
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.128
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.127
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.124
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.122
|
Mouse |
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.118
|
Mouse |
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.117
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.116
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.113
|
Mouse |
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.112
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.112
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.110
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.105
|
Mouse |
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.105
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.105
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.104
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.103
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.101
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.100
|
|
|
|
response to pain
|
GO:0048265 |
26 |
0.100
|
Mouse |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.099
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.098
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.098
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.097
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.095
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.094
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.093
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.091
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.090
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.089
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.089
|
Mouse |
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.088
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.088
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.087
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.086
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.085
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.085
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.084
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.083
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.082
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.082
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.080
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.080
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.078
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.077
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.077
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.077
|
Mouse |
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.077
|
Mouse |
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.075
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.075
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.074
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.073
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.072
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.072
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.071
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.070
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.069
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.068
|
Mouse |
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.068
|
|
|
|
learning
|
GO:0007612 |
98 |
0.067
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.067
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.067
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.066
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.066
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.065
|
Mouse |
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.065
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.064
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.064
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.063
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.063
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.062
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.062
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.061
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.060
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.060
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.060
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.059
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.058
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.058
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.058
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.058
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.057
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.057
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.057
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.057
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.056
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.056
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.056
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.056
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.056
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.055
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.055
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.055
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.055
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.054
|
Mouse |
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.054
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.053
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.052
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.052
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.052
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.052
|
Mouse |
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.051
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.051
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.050
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.050
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.050
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.049
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.049
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.049
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.049
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.049
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.049
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.048
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.048
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.048
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.047
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.047
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.047
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.046
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.046
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.046
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.045
|
Mouse |
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.045
|
|
|
|
superior vena cava morphogenesis
|
GO:0060578 |
1 |
0.045
|
|
|
|
visual behavior
|
GO:0007632 |
45 |
0.045
|
|
|
|
regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010578 |
3 |
0.044
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.044
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.044
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.044
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.044
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.044
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.043
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.043
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.043
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.043
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.043
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.042
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.042
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.042
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.042
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.042
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.041
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.041
|
|
|
|
negative regulation of purine nucleotide metabolic process
|
GO:1900543 |
16 |
0.041
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.041
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.041
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
2 |
0.041
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.040
|
Mouse |
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.040
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.040
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.040
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.040
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.040
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.040
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.039
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.039
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.039
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.039
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.039
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.039
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.039
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.039
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.039
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.039
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.038
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.038
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.037
|
Mouse |
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.037
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.037
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.037
|
|
|
|
tachykinin receptor signaling pathway
|
GO:0007217 |
1 |
0.037
|
|
|
|
establishment of neuroblast polarity
|
GO:0045200 |
1 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.037
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.036
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.036
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.036
|
|
|
|
regulation of corticosterone secretion
|
GO:2000852 |
2 |
0.036
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.035
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.035
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.035
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.035
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.035
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.035
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.035
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.035
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.035
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.035
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.034
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.034
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.033
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.033
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.033
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.033
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.033
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.033
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.033
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.033
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.032
|
|
|
|
general adaptation syndrome behavioral process
|
GO:0051867 |
1 |
0.032
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.032
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.032
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.032
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.032
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.032
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.032
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.032
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.032
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.032
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.032
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.031
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.031
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.031
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.031
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.031
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.031
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.031
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.031
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.030
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.030
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.030
|
|
|
|
positive regulation of white fat cell proliferation
|
GO:0070352 |
1 |
0.030
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.030
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.030
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.030
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.030
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.030
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.030
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.030
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.030
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.029
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.029
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.029
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.029
|
|
|
|
operant conditioning
|
GO:0035106 |
2 |
0.029
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.029
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.029
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.029
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.029
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.029
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
2 |
0.028
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.028
|
Mouse |
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.028
|
Mouse |
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
4 |
0.028
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.028
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.028
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.028
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.028
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.028
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.028
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.028
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.028
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.028
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
3 |
0.028
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.028
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.028
|
|
|
|
g protein coupled receptor internalization
|
GO:0002031 |
3 |
0.027
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.027
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.027
|
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.027
|
Mouse |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.027
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.027
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.027
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.026
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.026
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.026
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.026
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.026
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.026
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.026
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
26 |
0.026
|
Mouse |
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.026
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.026
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.026
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.025
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.025
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.025
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.025
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.025
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.025
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.025
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.025
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.025
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.025
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.024
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.024
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.024
|
|
|
|
dopamine catabolic process
|
GO:0042420 |
4 |
0.024
|
|
|
|
monoamine transport
|
GO:0015844 |
33 |
0.024
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.024
|
Mouse |
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.024
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.024
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.024
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.024
|
|
|
|
prevention of polyspermy
|
GO:0060468 |
4 |
0.024
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.024
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.024
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.023
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.023
|
|
|
|
positive regulation of camp biosynthetic process
|
GO:0030819 |
19 |
0.023
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.023
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.023
|
|
|
|
gastric acid secretion
|
GO:0001696 |
6 |
0.023
|
Mouse |
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.023
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.023
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
embryonic genitalia morphogenesis
|
GO:0030538 |
4 |
0.023
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.023
|
|
|
|
regulation of bone remodeling
|
GO:0046850 |
28 |
0.023
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.023
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.023
|
|
|
|
negative regulation of cyclic nucleotide metabolic process
|
GO:0030800 |
5 |
0.023
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.023
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.023
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.022
|
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.022
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.022
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.022
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.022
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.022
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.022
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.022
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.022
|
Mouse |
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.022
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.022
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.022
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.022
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.022
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.022
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.022
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.022
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.022
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.022
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.022
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.022
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.022
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.022
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.022
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.022
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.021
|
|
|
|
response to glucagon
|
GO:0033762 |
3 |
0.021
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.021
|
Mouse |
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.021
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.021
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
floor plate morphogenesis
|
GO:0033505 |
3 |
0.021
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.021
|
|
|
|
eating behavior
|
GO:0042755 |
15 |
0.021
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.021
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.021
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.021
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.021
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.021
|
Mouse |
|
|
nuclear division
|
GO:0000280 |
158 |
0.021
|
|
|
|
bronchiole morphogenesis
|
GO:0060436 |
1 |
0.020
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.020
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.020
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.020
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.020
|
|
|
|
digestion
|
GO:0007586 |
40 |
0.020
|
Mouse |
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.020
|
|
|
|
regulation of adenylate cyclase activity
|
GO:0045761 |
10 |
0.020
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.020
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.020
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
15 |
0.020
|
|
|
|
negative regulation of nucleotide metabolic process
|
GO:0045980 |
16 |
0.020
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.020
|
|
|
|
catecholamine transport
|
GO:0051937 |
21 |
0.020
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
25 |
0.020
|
|
|
|
negative regulation of adenylate cyclase activity
|
GO:0007194 |
1 |
0.020
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.020
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.020
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.020
|
Mouse |
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.020
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.020
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.020
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.020
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.020
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.020
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.020
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.019
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.019
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.019
|
|
|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
1 |
0.019
|
|
|
|
morphogenesis of an epithelial fold
|
GO:0060571 |
28 |
0.019
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.019
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.019
|
|
|
|
regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000583 |
2 |
0.019
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.019
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.019
|
|
|
|
regulation of sodium ion transport
|
GO:0002028 |
29 |
0.019
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.019
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.019
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.019
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.019
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.019
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.019
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.019
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.019
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.019
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.019
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.019
|
Mouse |
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.019
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.019
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.019
|
|
|
|
negative regulation of purine nucleotide biosynthetic process
|
GO:1900372 |
6 |
0.019
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.018
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
37 |
0.018
|
|
|
|
regulation of catecholamine secretion
|
GO:0050433 |
12 |
0.018
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.018
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.018
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.018
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.018
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.018
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.018
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.018
|
|
|
|
lactation
|
GO:0007595 |
25 |
0.018
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.018
|
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.018
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.018
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.018
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.018
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.018
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.017
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.017
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.017
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.017
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.017
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.017
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.017
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.017
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.017
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.017
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.017
|
|
|
|
positive regulation of cyclase activity
|
GO:0031281 |
11 |
0.017
|
|
|
|
positive regulation of adenylate cyclase activity
|
GO:0045762 |
8 |
0.017
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.017
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.017
|
|
|
|
positive regulation of cyclic nucleotide metabolic process
|
GO:0030801 |
24 |
0.017
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.017
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.017
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.017
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.017
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.017
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.017
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.017
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.017
|
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.017
|
|
|
|
regulation of potassium ion transport
|
GO:0043266 |
16 |
0.017
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.016
|
|